全球總體基因體學市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計總體基因體學市場將從 2025 年的 32 億美元成長到 2034 年的 102.2 億美元，2026 年至 2034 年的複合年成長率為 13.78%。

由於次世代定序技術在科學研究和診斷領域的快速應用，全球元基因組市場正經歷快速成長。元基因組分析能夠直接研究環境和臨床檢體中的遺傳物質，深入了解微生物多樣性和疾病機制。人們對微生物組研究和感染疾病監測日益成長的興趣是推動市場擴張的主要動力。

關鍵成長要素包括高通量定序平台和生物資訊學工具的技術進步。在農業、環境監測和藥物研發等領域的應用不斷拓展，進一步擴大了市場範圍。此外，研究經費的增加以及學術機構與生技公司之間合作的加強，正在加速總體基因體學領域的創新。

未來幾年，隨著定序成本的下降和數據分析能力的提升，市場預計將進一步受益。對個人化醫療和基於微生物組的治療方法的日益關注，有望開闢新的成長途徑。新興經濟體對基因組研究基礎設施的投資預計將會增加，從而支撐全球總體基因體學市場的持續擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球總體基因體學市場：依產品分類

• 市場分析、洞察與預測
• 試劑盒和試劑
• 定序和數據分析服務
• 軟體

第5章：全球宏總體基因體學市場：依技術分類

• 市場分析、洞察與預測
• 霰彈槍定序
• 16S定序
• 全基因測序
• 其他

第6章 全球宏總體基因體學市場：依工作流程分類

• 市場分析、洞察與預測
• 序列預處理
• 定序
• 數據分析

第7章 全球宏總體基因體學市場：依應用分類

• 市場分析、洞察與預測
• 環境
• 臨床診斷
• 藥物發現
• 生物技術
• 食品與營養
• 其他

第8章 全球總體基因體學市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Bio-Rad Laboratories Inc
  • Illumina Inc
  • PerkinElmer Inc
  • Thermo Fisher Scientific Inc
  • Novogene Co. Ltd
  • Promega Corporation
  • QIAGEN NV
  • Takara Bio Inc
  • Oxford Nanopore Technologies Plc
  • F. Hoffmann-La Roche Ltd

The Metagenomics Market size is expected to reach USD 10.22 Billion in 2034 from USD 3.20 Billion (2025) growing at a CAGR of 13.78% during 2026-2034.

The Global Metagenomics Market is witnessing rapid growth due to increasing adoption of next-generation sequencing technologies in research and diagnostics. Metagenomics enables the study of genetic material directly from environmental and clinical samples, offering insights into microbial diversity and disease mechanisms. Rising interest in microbiome research and infectious disease surveillance is significantly driving market expansion.

Major growth drivers include technological advancements in high-throughput sequencing platforms and bioinformatics tools. Expanding applications in agriculture, environmental monitoring, and drug discovery are further broadening the market scope. Additionally, increasing research funding and collaborations between academic institutions and biotechnology companies are accelerating innovation in metagenomics.

In the coming years, the market is expected to benefit from decreasing sequencing costs and improved data analysis capabilities. Growing focus on personalized medicine and microbiome-based therapeutics will likely create new growth avenues. Emerging economies are anticipated to increase investments in genomic research infrastructure, supporting sustained expansion of the global metagenomics market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Kits & Reagents
• Sequencing & Data Analytics Services
• Software

By Technology

• Shotgun Sequencing
• 16S Sequencing
• Whole Genome Sequencing
• Others

By Workflow

• Pre-sequencing
• Sequencing
• Data Analysis

By Application

• Environmental
• Clinical Diagnostics
• Drug Discovery
• Biotechnology
• Food & Nutrition
• Others

COMPANIES PROFILED

• BioRad Laboratories Inc, Illumina Inc, PerkinElmer Inc, Thermo Fisher Scientific Inc, Novogene Co Ltd, Promega Corporation, QIAGEN NV, Takara Bio Inc, Oxford Nanopore Technologies plc, F HoffmannLa Roche Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL METAGENOMICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Sequencing & Data Analytics Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL METAGENOMICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Shotgun Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. 16S Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Whole Genome Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL METAGENOMICS MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Workflow
• 6.2. Pre-sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL METAGENOMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Environmental Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Food & Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL METAGENOMICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Technology
  • 8.2.3 By Workflow
  • 8.2.4 By Application
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Technology
  • 8.3.3 By Workflow
  • 8.3.4 By Application
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Technology
  • 8.4.3 By Workflow
  • 8.4.4 By Application
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Technology
  • 8.5.3 By Workflow
  • 8.5.4 By Application
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Technology
  • 8.6.3 By Workflow
  • 8.6.4 By Application
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL METAGENOMICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Bio-Rad Laboratories Inc
  • 10.2.2 Illumina Inc
  • 10.2.3 PerkinElmer Inc
  • 10.2.4 Thermo Fisher Scientific Inc
  • 10.2.5 Novogene Co. Ltd
  • 10.2.6 Promega Corporation
  • 10.2.7 QIAGEN N.V
  • 10.2.8 Takara Bio Inc
  • 10.2.9 Oxford Nanopore Technologies Plc
  • 10.2.10 F. Hoffmann-La Roche Ltd